Clinical Trial

A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis

Name: A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis — clinical trial record (NCT07158151)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 2

View on ClinicalTrials.gov →

Summary

This study is ongoing to explore the efficacy and safety of different strengths of RSS0393 ointment in adults with atopic dermatitis

Protocol Amendment History 2 changes

critical Trial completed 2026-04-30

notable Primary completion pushed: 2026-03 -> 2026-04-10 2026-04-30

Trial Details

NCT Number	NCT07158151
Lead Sponsor	Reistone Biopharma Company Limited
Conditions	Atopic Dermatitis of Adults
Enrollment	168 participants
Start Date	2025-09-25
Primary Completion	2026-04-10 (estimated)
Study Completion	2026-04-10 (estimated)
Updated on ClinicalTrials.gov	2026-04-29